Defining Research and Care in Diabetes in Pregnancy

妊娠期糖尿病研究和护理的定义

基本信息

批准号：
10753647
负责人：
SCOTT A SULLIVAN
金额：
$ 1万
依托单位：
INOVA HEALTH CARE SERVICES
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-08-15 至 2024-07-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10753647
关键词：
Address Area Basic Science Caring Church Clinical Clinical Sciences Collaborations Communities Community Health Aides Dedications Diabetes Mellitus Discipline of obstetrics Disease Endocrinologist Epidemic Faculty Fostering Future Generations Gestational Diabetes Goals Health Health Professional Hybrids Individual International Location Maternal-fetal medicine Medical Memory Non-Insulin-Dependent Diabetes Mellitus North America Nurses Oral Outcome Participant Patients Personal Satisfaction Persons Physicians Policy Maker Pregnancy in Diabetics Pregnant Women Prevention Primary Care Physician Public Health Public Policy Recording of previous events Research Research Personnel Risk Factors Scientist Specialist Students Time Translational Research United States cardiometabolism career clinical care data dissemination diabetes educator driving force falls improved innovation interest lectures low and middle-income countries meetings novel offspring pregnant profession allied to medicine programs social social health determinants symposium tool type I and type II diabetes undergraduate student virtual

项目摘要

PROJECT SUMMARY The 17th biennial meeting of the Diabetes in Pregnancy Study Group of North America (DPSG-NA) will be held on October 26-28, 2023 as a hybrid virtual and in-person meeting at the Physicians Conference Center at Inova Fairfax Medical Campus in Falls Church, VA. This 3-day research meeting focuses on pregnant individuals living with type 1, type 2, and gestational diabetes mellitus. Since its inception over 25 years ago, the DPSG-NA meetings have been a vehicle for the dissemination of data, gathered through collaboration among basic, translational, clinical, and public health researchers and practitioners both in the United States and abroad. The meeting covers a broad range of issues related to diabetes in pregnancy. The focus of the meeting is to highlight major, timely research areas to catalyze future discovery. The major goal of this meeting is, and has historically been, to serve as a driving force for discussions and new collaborations that open novel areas of exploration into prevention, treatment, and management approaches. These efforts are expected to reduce the burden of diabetes disease and its consequences for pregnant individuals and their offspring. The 17h biennial meeting has a strong emphasis on diversity, emphasizing the importance of social determinants of health and global perspectives, including low-and-middle-income countries. The meeting goals will be achieved through oral presentations, roundtable discussions, and debates that will bring together the world’s experts, young investigators, students, and trainees who have a committed interest to diabetes in pregnancy. The program includes 4 keynote addresses that each will be dedicated to a giant in the field of diabetes in pregnancy. The first keynote will be given in memory of Oded Langer by Roberto Romero, MD, DMed, Sci. Dr. Romero will speak on the prediction and prevention of obstetrical diseases. In addition, Cynthia Gyamfi-Bannerman, MD, MS will give the Elizabeth Thom Memorial Lecture where Dr. Gyamfi-Bannerman will speak of Dr. Thom’s contribution as the biostatistician of the MFMU network in changing clinical care in diabetes. Finally, Kevan Herold, MD will speak in the Lois Jovanovic Memorial Lecture and will address strategies to reduce the diabetes epidemic in the United States. Other speakers include established experts and young investigators, with about 20% of the meeting time allocated for speaker-conferee discussions. Young investigator presentations are an important aspect of the meeting, and they are an effective tool to help bring a new generation of scientists into our community and foster their maturation. Informal discussions among conferees are highlights of this unique meeting that fosters a collaborative, multifaceted approach to improving the health and wellbeing of pregnant women with diabetes and their offspring.

项目概要北美妊娠期糖尿病研究组（DPSG-NA）第17届双年度会议即将召开 2023 年 10 月 26 日至 28 日在 Inova 医师会议中心举行虚拟和现场混合会议位于弗吉尼亚州福尔斯彻奇的费尔法克斯医学园区这个为期 3 天的研究会议重点关注孕妇。自 25 年前成立以来，DPSG-NA 一直致力于治疗 1 型、2 型和妊娠期糖尿病。会议已成为传播数据的工具，这些数据是通过基础、美国和国外的转化、临床和公共卫生研究人员和从业人员。会议涵盖了与妊娠期糖尿病相关的广泛问题。会议的重点是强调。促进未来发现的重大、及时的研究领域是本次会议的主要目标，而且历来都是如此。一直，作为讨论和新合作的驱动力，开辟新的探索领域这些努力有望减轻疾病的负担。糖尿病及其对孕妇及其后代的影响 17h 每两年一次的会议。高度重视多样性，强调健康和全球社会决定因素的重要性会议目标将通过口头方式实现。演讲、圆桌讨论和辩论将汇集世界各地的专家、年轻人对妊娠期糖尿病感兴趣的研究人员、学生和实习生。包括 4 场主题演讲，每场演讲都献给妊娠期糖尿病领域的一位巨头。医学博士、医学博士、科学博士罗伯托·罗梅罗 (Roberto Romero) 将为纪念奥德·兰格 (Oded Langer) 发表第一个主题演讲。此外，Cynthia Gyamfi-Bannerman 医学博士还发表了关于产科疾病的预测和预防的演讲。 MS 将在 Elizabeth Thom 纪念演讲中 Gyamfi-Bannerman 博士将讲述 Thom 博士的作为 MFMU 网络的生物统计学家，Kevan 在改变糖尿病临床护理方面做出了贡献。 Herold 医学博士将在 Lois Jovanovic 纪念讲座上发表讲话，并将讨论减少糖尿病的策略其他发言者包括知名专家和年轻的研究人员，人数约为分配给演讲者与与会者讨论的会议时间中有 20% 是青年研究者的演讲。会议的一个重要方面，它们是帮助新一代科学家进入的有效工具我们的社区并促进与会者之间的非正式讨论是这一独特的亮点。会议旨在促进采取多方面的协作方法来改善孕妇的健康和福祉患有糖尿病的妇女及其后代。